6,989
Views
93
CrossRef citations to date
0
Altmetric
Research Article

Scalp cooling for hair preservation and associated characteristics in 1411 chemotherapy patients - Results of the Dutch Scalp Cooling Registry

, , , , &
Pages 497-504 | Received 23 Sep 2011, Accepted 13 Jan 2012, Published online: 06 Feb 2012

References

  • Hurk van den CJ, Mols F, Vingerhoets AJ, Breed WP. Impact of alopecia and scalp cooling on the well-being of breast cancer patients. Psycho-oncology 2010;19:701–9.
  • Mulders M, Vingerhoets A, Breed W. The impact of cancer and chemotherapy: Perceptual similarities and differences between cancer patients, nurses and physicians. Eur J Oncol Nurs 2008;12:97–102.
  • Janssen FE. Modelling physiological and biochemical aspects of scalp cooling. Eindhoven: Technical University Eindhoven; 2007. Thesis.
  • Hurk van den CJG, Gerrits P, Graat J, Kolen B, Laar van de-Müskens J, Breed WPM. Positieve ervaringen met hoofdhuidkoeling in drie ziekenhuizen in Nederland. Tijd voor een standaard aanbod van hoofdhuidkoeling? Oncologica 2005;22:162–67 [Dutch].
  • Christodoulou C, Tsakalos G, Galani E, Skarlos DV. Scalp metastases and scalp cooling for chemotherapy-induced alopecia prevention. Ann Oncol 2006;17:350.
  • Breed WPM, Hurk van den CJG, Peerbooms M. Presentation, impact and prevention of chemotherapy-induced hair loss; scalp cooling potentials and limitations. Expert Review Dermatol 2011;6:109–25.
  • Grevelman EG, Breed WP. Prevention of chemotherapy-induced hair loss by scalp cooling. Ann Oncol 2005;16:352–8.
  • Konishi Y, Kuroki T. Prevention of adrimycin-induced alopecia by scalp hypothermia with a deep-frozen Duncool-cap. Gan To Kagaku Ryoho 1988;15:3081–5.
  • Nakazawa M, Sakamoto T, Honda M, Sawa Y, Sato K, Oguro K, . Scalp hypothermia: A prevention of hair-loss in clinical oncology. Dokkyo J Med Sci 1985;12:17–24.
  • Keizer-Heldens P. Hoofdhuidkoeling bij haarverlies door chemotherapie. Oncologica. 2009;29–34 [Dutch].
  • Kargar M, Sarvestani RS, Khojasteh HN, Heidari MT. Efficacy of penguin cap as scalp cooling system for prevention of alopecia in patients undergoing chemotherapy. J Adv Nurs 2011;67:2473–7.
  • Geerts P, Hendriks M, van den Hurk C, Dercksen M, Breed W. Hair preservation in FEC-chemotherapy; not an exception. 2011 (submitted).
  • World Health Organisation. Handbook for Reporting Results of Cancer Treatment. Geneva: WHO Offset Publ.; 1979.
  • Babyak MA. What you see may not be what you get: A brief, nontechnical introduction to overfitting in regression-type models. Psychosom Med 2004;66:411–21.
  • Auvinen PK, Mahonen UA, Soininen KM, Paananen PK, Ranta-Koponen PH, Saavalainen IE, . The effectiveness of a scalp cooling cap in preventing chemotherapy-induced alopecia. Tumori 2010;96:271–5.
  • Massey CS. A multicentre study to determine the efficacy and patient acceptability of the Paxman Scalp Cooler to prevent hair loss in patients receiving chemotherapy. Eur J Oncol Nurs 2004;8:121–30.
  • Kato M, Sakuyama A, Imai R, Kobayashi T. Evaluation of dignicap system for the prevention of chemotherapy-induced hair loss in breast cancer patient. Breast 2011;20(Suppl 1):S80, abstr 811.
  • Lenaerts E, Meyen M, Maes T, El Mousati A, Lemmens J, . Scalp cooling in the prevention of anthracycline-induced alopecia. Eur J Cancer 2001;37(Suppl 6):360.
  • Peck HJ, Mitchell H, Stewart AL. Evaluating the efficacy of scalp cooling using the Penguin cold cap system to reduce alopecia in patients undergoing chemotherapy for breast cancer. Eur J Oncol Nurs 2000;4:246–8.
  • Hurk van den CJG, Breed WPM, Nortier JWR. Short post-infusion scalp cooling times in the prevention of docetaxel-induced alopecia. 2011 (submitted).
  • Kingsley CD. Hypersensitivity reactions. In: Perry MC, editor. The chemotherapy source book. Philadelphia: Wolters Kluwer Health; 2008.
  • Rasheed ZA, Rubin EH. Topoisomerase-interacting agents. In: DeVita VT, Lawrence TS, Rosenberg SA, editors. Cancer principles & practice of oncology. 8th ed. Philadelphia: Wolters Kluwer Health; 2008. pp. 437–44.
  • Williams C, Bryant A. Short versus long duration infusions of paclitaxel for any advanced adenocarcinoma. Cochrane database of systematic reviews (Online). 2011;5:CD003911.
  • Mikkelsen TS, Sparreboom A, Cheng C, Zhou Y, Boyett JM, Raimondi SC, . Shortening infusion time for high-dose methotrexate alters antileukemic effects: A randomized prospective clinical trial. J Clin Oncol 2011;29:1771–8.
  • Macduff C, Mackenzie T, Hutcheon A, Melville L, Archibald H. The effectiveness of scalp cooling in preventing alopecia for patients receiving epirubicin and docetaxel. Eur J Cancer Care (Engl) 2003;12:154–61.
  • Holowatz LA, Kenney WL. Peripheral mechanisms of thermoregulatory control of skin blood flow in aged humans. J Appl Physiol 2010;109:1538–44.
  • Hurria A, Lichtman SM. Pharmacokinetics of chemotherapy in the older patient. Cancer Control 2007;14:32–43.
  • Hurk van den CJG, Breed WPM, Mols F. Chemotherapy-induced hair loss. In: Preedy VE, editor. Handbook of Hair in Health and Disease. Wageningen, The Netherlands: Wageningen Academic Publishers; 2012; p. 403–16.
  • O'Donnell PH, Dolan ME. Cancer pharmacoethnicity: Ethnic differences in susceptibility to the effects of chemotherapy. Clin Cancer Res 2009;15:4806–14.
  • Blume-Peytavi U, Tosti A, Whiting DA, Trueb RM. Hair growth and disorders. Berlin: Springer Verlag; 2008.
  • Franbourg A, Hallegot P, Baltenneck F, Toutain C, Leroy F. Current research on ethnic hair. J Am Acad Dermatol 2003;48:S115–9.
  • Takahashi T, Hayashi R, Okamoto M, Inoue S. Morphology and properties of Asian and Caucasian hair. J Cosmet Sci 2006;57:327–38.
  • Loussouarn G, El Rawadi C, Genain G. Diversity of hair growth profiles. Int J Dermatol 2005;44(Suppl 1):6–9.
  • Hilton S, Hunt K, Emslie C, Salinas M, Ziebland S. Have men been overlooked? A comparison of young men and women's experiences of chemotherapy-induced alopecia. Psycho-oncology 2008;17:577–83.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.